Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Postbiotics derived from recombinant lactic acid bacteria exhibit high IL6-binding capacity and suppress IL6-induced STAT3 signaling
Authors:ID Zahirović, Abida, Institut "Jožef Stefan" (Author)
ID Zupančič, Špela (Author)
ID Verdir, Andraž, Institut "Jožef Stefan" (Author)
ID Nemec, Sebastjan, Institut "Jožef Stefan" (Author)
ID Kralj, Slavko, Institut "Jožef Stefan" (Author)
ID Snoj, Luka, Institut "Jožef Stefan" (Author)
ID Berlec, Aleš, Institut "Jožef Stefan" (Author)
Files:URL URL - Source URL, visit https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1657810/full
 
.pdf PDF - Presentation file, download (2,98 MB)
MD5: 235A1B5C03C3CA8ECA7BFE373E826011
 
Language:English
Typology:1.02 - Review Article
Organization:Logo IJS - Jožef Stefan Institute
Abstract:Introduction: With growing evidence of clinical efficacy of probiotics in various diseases, safety concerns have arisen regarding the therapeutic use of live probiotic bacteria, especially in critically ill, immunocompromised, and pediatric populations. Serious probiotic-related adverse effects have been reported in these patients, including bloodstream infection and sepsis. This has led to an increased interest in developing postbiotics (non-viable bacterial products) that may exert beneficial effects on the host without the risks associated with administration of live microorganisms. The aim of this study was to explore postbiotic potential of recombinant Lactococcus lactis bacteria that have been engineered to display interleukin 6 (IL6)-targeting affibody (ZIL6) on their surface and are intended for treatment of inflammatory intestinal diseases. Methods: Five different killing treatments were applied to kill bacteria (heat, ethanol, sonication, UV, and gamma irradiation) and their effect on bacterial viability, morphology and functionality was examined in vitro using a combination of different techniques, including microscopy, flow cytometry, immunoassays and cell-based reporter assay. Results: The results showed that ZIL6 affibody displayed on L. lactis via non-covalent anchoring withstood the treatments applied to kill bacteria and remained functional after the loss of microbial viability. The degree of functionality was dependent on the type of treatment. Heat-killed cells retained 50% of the activity of live strain, while most of the activity was preserved after exposure of bacteria to ethanol, sonication, UV and gamma irradiation. The applied treatments varied in killing efficacy, whereby ethanol and heat rendered bacteria non-viable, UV and gamma irradiation yielded non-replicative cells, whereas sonication was ineffective in killing L. lactis. Among non-viable cells, ethanol-killed bacteria exhibited the greatest activity and showed high maximum binding capacity of 200 ng IL6 per mg dry cell weight, possessed strong nanomolar affinity for IL6, and inhibited up to 78% of IL6-induced STAT3 signaling. Conclusion: The study demonstrates that functional non-viable bacterial cells can be derived from the recombinant L. lactis with therapeutic proteins displayed on their surface and provides a good foundations for further studies of their postbiotic potential in adjunctive therapy of inflammatory intestinal diseases.
Keywords:affibody, probiotics, postbiotics, Lactococcus lactis
Publication status:Published
Publication version:Version of Record
Submitted for review:16.07.2025
Article acceptance date:02.10.2025
Publication date:24.10.2025
Publisher:Frontiers
Year of publishing:2025
Number of pages:str. 1-19
Numbering:Vol. 16
Source:Švica
PID:20.500.12556/DiRROS-23989 New window
UDC:615
ISSN on article:1664-302X
DOI:10.3389/fmicb.2025.1657810 New window
COBISS.SI-ID:255694595 New window
Copyright:© 2025 Zahirović, Zupančič, Verdir, Nemec, Kralj, Snoj and Berlec.
Note:Nasl. z nasl. zasl.; Soavtorji: Špela Zupančič, Andraž Verdir, Sebastjan Nemec, Slavko Kralj, Luka Snoj, Aleš Berlec; Opis vira z dne 3. 11. 2025;
Publication date in DiRROS:03.11.2025
Views:196
Downloads:101
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in microbiology
Shortened title:Front. microbiol.
Publisher:Frontiers Research Foundation
ISSN:1664-302X
COBISS.SI-ID:4146296 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z4-4566-2022
Name:Razvoj mlečnokislinskih bakterij za ciljano dostavo protitumorskih učinkovin

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0127-2019
Name:Farmacevtska biotehnologija: znanost za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-4418-2022
Name:Nanovlakna za sočasno dostavo koktajlov izbrane mikrobiote in protimikrobnih učinkovin za lokalno zdravljenje vaginalnih infekcij

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J2-60047-2025
Name:Magnetno mikrostrukturiranje površin iz Mg zlitine za izboljšano endotelizacijo in zadržano razgradljivost materialov žilnih opornic

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:24.10.2025
Applies to:VoR

Secondary language

Language:Slovenian
Keywords:probiotiki, postbiotiki, Lactococcus lactis, mlečnokislinske bakterije


Back